Management of unresectable non-metastatic non-small cell lung cancer. Guidelines of clinical practice made by the European Lung Cancer Working Party;Traitement des cancers bronchiques non à petites cellules, non métastatiques et non résécables. Recommandations de pratique clinique de l'European Lung Cancer Working Party

Revue Medicale de Bruxelles

Volumn 27, Issue 3, 2006, Pages 152-161

  Sculier, J P ^a  

^a JULES BORDET INSTITUTE   (Belgium)

Author keywords

Guidelines; Non small cell lung cancer; Recommendations

Indexed keywords

RADIOSENSITIZING AGENT;

ARTICLE; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CARCINOGENESIS; CLINICAL PRACTICE; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; PRACTICE GUIDELINE; TREATMENT CONTRAINDICATION;

CARCINOMA, NON-SMALL-CELL LUNG; EUROPE; LUNG NEOPLASMS; NEOPLASM STAGING;

EID: 33746029953     PISSN: 00353639     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Traitement des cancers bronchiques non à petites cellules et résécables. Recommandations de pratique clinique de l'European Lung Cancer working Party. Rev Med Brux 2006; 27: 29-38
2. Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project. Qual Saf Health Care 2003; 12: 18-23
3. Burgers JS, Fervers B, Haugh M et al: International assessment of the quality of clinical practice guidelines in oncology using the Appraisal of Guidelines and Research and Evaluation Instrument. J Clin Oncol 2004; 22: 2000-7
4. Clinical practice guidelines for the treatment of unresectable non-small cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology. J Clin Oncol 1997; 15: 2996-3018
5. Pfister DG, Johnson DH, Azzoli CG et al: American Society of Clinical Oncology treatment of unresectable non-small cell lung cancer guideline: update 2003. J Clin Oncol 2004; 22: 330-53
6. BTS guidelines: guidelines on the selection of patients with lung cancer for surgery. Thorax 2001; 56: 89-108
7. Levine M, Browman G, Newman T, Cowan DH: The Ontario Cancer Treatment Practice Guidelines Initiative. Oncology (Huntingt) 1996; 10 (Suppl 11): 19-22
8. The Royal College of Radiologists Clinical Oncology Information Network: Guidelines on the non-surgical management of lung cancer. Clin Oncol (R Coll Radiol) 1999; 11: S1-53
9. Alberts WM: Lung Cancer Guidelines. Introduction. Chest 2003; 123: 1S-2S
10. Depierre A, Lagrange JL, Theobald S et al: Standards, Options et Recommandations 2000 pour la prise en charge des patients atteints d'un cancer bronchopulmonaire non à petites cellules (rapport abrégé). Bull Cancer 2003; 90: 151-66
11. McCrory DC, Colice GL, Lewis SZ, Alberts WM, Parker S: Overview of methodology for lung cancer evidence review and guideline development. Chest 2003; 123 (Suppl 1): 3S-6S
12. Mittal BB, Gruhn JG, Brand WN: Radiotherapy in lung cancer: a perspective from Roentgen to current concepts. In: Gruhn JG, Rosen ST, eds. Lung Cancer. The evolution of concepts. Volume II. New York, Field and Wood, 1989: 55-72
13. Non-small Cell Lung Cancer Collaborative Group: Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ 1995; 311: 899-909
14. Damstrup L, Poulsen HS: Review of the curative role of radiotherapy in the treatment of non-small cell lung cancer. Lung Cancer 1994; 11: 153-78
15. Rowell NP, Williams CJ: Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): a systematic review. Thorax 2001; 56: 628-38
16. Saunders M, Dische S, Barrett A, Harvey A, Griffiths G, Palmar M: Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial. CHART Steering committee [In Process Citation]. Radiother Oncol 1999; 52: 137-48
17. Depierre A, Lagrange JL, Theobald S et al: Standards, Options and Recommendations for the management of non-small cell lung carcinoma patients. Br J Cancer 2003; 89 (Suppl 1): S35-49
18. Rodrigues G, Lock M, D'Souza D, Yu E, Van Dyk J: Prediction of radiation pneumonitis by dose - volume histogram parameters in lung cancer - a systematic review. Radiother Oncol 2004; 71: 127-38
19. Mattson K, Holsti LR, Holsti P et al: Inoperable non-small cell lung cancer: radiation with or without chemotherapy. Eur J Cancer Clin Oncol 1988; 24: 477-82
20. Dillman RO, Seagren SL, Propert KJ et al: A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer. N Engl J Med 1990; 323: 940-5
21. Dillman RO, Herndon J, Seagren SL, Eaton WLJ, Green MR: Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial. J Natl Cancer Inst 1996; 88: 1210-5
22. Morion RF, Jett JR, McGinnis WL et al: Thoracic radiation therapy alone compared with combined chemoradiotherapy for locally unresectable non-small cell lung cancer. A randomized, phase III trial. Ann Intern Med 1991; 115: 681-6
23. Le Chevalier T, Arriagada R, Quoix E et al: Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients. J Natl Cancer Inst 1991; 83: 417-23
24. Le Chevalier T, Arriagada R, Tarayre M et al: Significant effect of adjuvant chemotherapy on survival in locally advanced non-small cell lung carcinoma. J Natl Cancer Inst 1992; 84: 58
25. Gregor A, Macbeth FR, Paul J, Cram L, Hansen HH: Radical radiotherapy and chemotherapy in localized inoperable non-small cell lung cancer: a randomized trial. J Natl Cancer Inst 1993; 85: 997-9
26. Crino L, Latini P, Meacci M et al: Induction chemotherapy plus high-dose radiotherapy versus radiotherapy alone in locally advanced unresectable non-small cell lung cancer. Ann Oncol 1993; 4: 847-51
27. Wolf M, Hans K, Becker H et al: Radiotherapy alone versus chemotherapy with ifosfamide/vindesine followed by radiotherapy in unresectable locally advanced non-small cell lung cancer. Semin Oncol 1994; 21 (3 Suppl 4): 42-7
28. Sause WT, Scott C, Taylor S et al: Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small cell lung cancer. J Natl Cancer Inst 1995; 87: 198-205
29. Sause W, Kolesar P, Taylor S et al: Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group. Chest 2000; 117: 358-64
30. Planting A, Helle P, Drings P et al: A randomized study of high-dose split course radiotherapy preceded by high-dose chemotherapy versus high-dose radiotherapy only in locally advanced non-small cell lung cancer. An EORTC Lung Cancer Cooperative Group trial. Ann Oncol 1996; 7: 139-44
31. Brodin O, Nou E, Mercke C et al: Comparison of induction chemotherapy before radiotherapy with radiotherapy only in patients with locally advanced squamous cell carcinoma of the lung. The Swedish Lung Cancer Study Group. Eur J Cancer 1996; 32A: 1893-900
32. Cullen MH, Billingham LJ, Woodroffe CM et al: Mitomycin, Ifosfamide, and Cisplatin in Unresectable Non-Small Cell Lung Cancer: Effects on Survival and Quality of Life. J Clin Oncol 1999; 17: 3188-94
33. Mattson KV, Abratt RP, Ten Velde G, Krofta K: Docetaxel as neoadjuvant therapy for radically treatable stage III non-small cell lung cancer: a multinational randomised phase III study. Ann Oncol 2003; 14: 116-22
34. Sculier JP, Berghmans T, Paesmans M et al: La place de la chimiothérapie dans le traitement des cancers bronchiques non à petites cellules non métastatiques. Rev Med Brux 2001; 22: 477-87
35. Trovo MG, Minatel E, Franchin G et al: Radiotherapy versus radiotherapy enhanced by cisplatin in stage III non-small cell lung cancer. Int J Radiat Oncol Biol Phys 1992; 24: 11-5
36. Blanke C, Ansari R, Mantravadi R et al: Phase III trial of thoracic irradiation with or without cisplatin for locally advanced unresectable non-small cell lung cancer: a Hoosier Oncology Group protocol. J Clin Oncol 1995; 13: 1425-9
37. Jeremic B, Shibamoto Y, Acimovic L, Djuric L: Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III non-small cell lung cancer. J Clin Oncol 1995; 13: 452-8
38. Jeremic B, Shibamoto Y, Acimovic L, Milisavljevic S: Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/ etoposide for stage III non-small cell lung cancer: a randomized study. J Clin Oncol 1996; 14: 1065-70
39. Bonner JA, McGinnis WL, Stella PJ et al: The possible advantage of hyperfractionated thoracic radiotherapy in the treatment of locally advanced non small-cell lung carcinoma: results of a North Central Cancer Treatment Group Phase III Study. Cancer 1998; 82: 1037-48
40. Ball D, Bishop J, Smith J et al: A randomised phase III study of accelerated or standard fraction radiotherapy with or without concurrent carboplatin in inoperable non-small cell lung cancer: final report of an Australian multi-centre trial. Radiother Oncol 1999; 52: 129-36
41. Clamon G, Herndon J, Cooper R, Chang AY, Rosenman J, Green MR: Radiosensitization with carboplatin for patients with unresectable stage III non-small cell lung cancer: a phase III trial of the Cancer and Leukemia Group B and the Eastern Cooperative Oncology Group. J Clin Oncol 1999; 17: 4-11
42. Groen HJ, Van Der Leest AH, Fokkema E et al: Continuously infused carboplatin used as radiosensitizer in locally unresectable non-small cell lung cancer: a multicenter phase III study. Ann Oncol 2004; 15: 427-32
43. Cakir S, Egehan I: A randomised clinical trial of radiotherapy plus cisplatin versus radiotherapy alone in stage III non-small cell lung cancer. Lung Cancer 2004; 43: 318
44. Schaake-Koning C, van den Bogaert W, Dalesio O et al: Effects of concomitant cisplatin and radiotherapy on inoperable non-small cell lung cancer. N Engl J Med 1992; 326: 524-30
45. Rakovitch E, Tsao M, Ung Y, Pignol JP, Cheung P, Chow E: Comparison of the efficacy and acute toxicity of weekly versus daily chemoradiotherapy for non-small cell lung cancer: a meta-analysis. Int J Radiat Oncol Biol Phys 2004; 58: 196-203
46. Johnson DH, Einhorn LH, Bartolucci A et al: Thoracic radiotherapy does not prolong survival in patients with locally advanced, unresectable non-small cell lung cancer. Ann Intern Med 1990; 113: 33-8
47. Kubota K, Furuse K, Kawahara M et al: Role of radiotherapy in combined modality treatment of locally advanced non-small cell lung cancer. J Clin Oncol 1994; 12: 1547-52
48. Sculier JP, Paesmans M, Lafitte JJ et al: A randomised phase III trial comparing consolidation treatment with further chemotherapy to chest irradiation in patients with initially unresectable locoregional non-small cell lung cancer responding to induction chemotherapy. European Lung Cancer Working Party. Ann Oncol 1999; 10: 295-303
49. Kaasa S, Thorud E, Host H, Lien HH, Lund E, Sjolie I: A randomized study evaluating: radiotherapy versus chemotherapy in patients with inoperable non-small cell lung cancer. Radiother Oncol 1988; 11: 7-13
50. Johnstone DW, Byhardt RW, Ettinger D, Scott CB: Phase III study comparing chemotherapy and radiotherapy with preoperative chemotherapy and surgical resection in patients with non-small cell lung cancer with spread to mediastinal lymph nodes (N2); final report of RTOG 89-01. Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 2002; 54: 365-9
51. Komaki R, Seiferheld W, Ettinger D, Lee JS, Movsas B, Sause W: Randomized phase II chemotherapy and radiotherapy trial for patients with locally advanced inoperable non-small cell lung cancer: long-term follow-up of RTOG 92-04. Int J Radiat Oncol Biol Phys 2002; 53: 548-57
52. Belani CP, Choy H, Bonomi P et al: Combined chemoradiotherapy regimens of paclitaxel and carboplatin for locally advanced non-small cell lung cancer: a randomized phase II locally advanced multi-modality protocol. J Clin Oncol 2005; 23: 5883-91
53. Furuse K, Fukuoka M, Kawahara M et al: Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small cell lung cancer. J Clin Oncol 1999; 17: 2692
54. Zatloukal P, Petruzelka L, Zemanova M et al: Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study. Lung Cancer 2004; 46: 87-98
55. Fournel R Robinet G, Thomas P et al: Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Francais de Pneumo-Cancerologie NPC 95-01 Study. J Clin Oncol 2005; 23: 5910-7
56. Vokes EE, Herndon JE, Crawford J et al: Randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy for stage IUB non-small cell lung cancer: cancer and leukemia group B study 9431. J Clin Oncol 2002; 20: 4191-8
57. Sculier JP, Lafitte JJ, Berghmans T et al: A phase III randomised study comparing two different dose-intensity regimens as induction chemotherapy followed by thoracic irradiation in patients with advanced locoregional non-small cell lung cancer. Ann Oncol 2004; 5: 399-409
58. Belani CP, Wang W, Johnson DH et al: Phase III study of the Eastern Cooperative Oncology Group (ECOG 2597): induction chemotherapy followed by either standard thoracic radiotherapy or hyperfractionated accelerated radiotherapy for patients with unresectable stage IIIA and B non-small-cell lung cancer. J Clin Oncol 2005; 23: 3760-7
59. Senan S, De Ruysscher D, Giraud P, Mirimanoff R, Budach V: Literature-based recommendations for treatment planning and execution in high-dose radiotherapy for lung cancer. Radiother Oncol 2004; 71: 139-46
60. Armstrong JG: Target volume definition for three-dimensional conformai radiation therapy of lung cancer. Br J Radiol 1998; 71: 587-94
61. Bradley JD, Scott CB, Paris KJ et al: A phase III comparison of radiation therapy with or without recombinant beta-interferon for poor-risk patients with locally advanced non-small cell lung cancer (RTOG 93-04). Int J Radiat Oncol Biol Phys 2002; 52: 1173-9
62. Marino P, Preatoni A, Cantoni A: Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb non-small cell lung cancer. A meta-analysis. Cancer 1995; 76: 593-601
63. Pritchard RS, Anthony SP: Chemotherapy plus radiotherapy compared with radiotherapy alone in the treatment of locally advanced, unresectable, non-small cell lung cancer. A meta-analysis [published erratum appears in Ann Intern Med 1997; 126: 670]. Ann Intern Med 1996; 125: 723-9